Literature DB >> 20969621

The role of mitochondrial complex III in melatonin-induced ROS production in cultured mesangial cells.

Hong-Mei Zhang1, Yiqiang Zhang, Bin-Xian Zhang.   

Abstract

Melatonin is a potent scavenger of reactive oxygen (ROS) and reactive nitrogen species (RNS). At pharmacological concentrations, however, melatonin is documented to cause ROS/RNS production, especially in cultured cancerous cells. Currently, the mechanism responsible for melatonin-induced ROS generation remains elusive. In this study, we provided evidence that melatonin, at micromolar concentrations, induced rapid ROS generation by a mitochondrial-dependent mechanism in primary human mesangial (HM) cells. The melatonin-induced ROS production occurred independent of changes in Ca(2+) concentrations in the cytosol and/or in mitochondria. In mitochondria isolated from HM cells and mice kidney tissues, melatonin caused ROS production; this melatonin response was completely blocked by the complex III inhibitor antimycin A. In contrast, both the mitochondrial complex I inhibitor, rotenone, and another complex III inhibitor, myxothiazol, which interacts with complex III at a distinct site, had no significant inhibitory effect on melatonin-induced ROS generation. These results demonstrate that melatonin induced rapid ROS generation via the antimycin A-sensitive site of mitochondrial complex III. Journal of Pineal Research
© 2010 John Wiley & Sons A/S. No claims to US government works.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20969621      PMCID: PMC3005809          DOI: 10.1111/j.1600-079X.2010.00815.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  25 in total

1.  Myxothiazol induces H(2)O(2) production from mitochondrial respiratory chain.

Authors:  A A Starkov; G Fiskum
Journal:  Biochem Biophys Res Commun       Date:  2001-03-02       Impact factor: 3.575

2.  Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy.

Authors:  Mehdi H Shishehbor; Ronnier J Aviles; Marie-Luise Brennan; Xiaoming Fu; Marlene Goormastic; Gregory L Pearce; Noyan Gokce; John F Keaney; Marc S Penn; Dennis L Sprecher; Joseph A Vita; Stanley L Hazen
Journal:  JAMA       Date:  2003-04-02       Impact factor: 56.272

3.  Evidence of prooxidant and antioxidant action of melatonin on human liver cell line HepG2.

Authors:  R A Osseni; P Rat; A Bogdan; J M Warnet; Y Touitou
Journal:  Life Sci       Date:  2000-12-15       Impact factor: 5.037

4.  Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy.

Authors:  R C Thuraisingham; C A Nott; S M Dodd; M M Yaqoob
Journal:  Kidney Int       Date:  2000-05       Impact factor: 10.612

5.  Melatonin and taurine reduce early glomerulopathy in diabetic rats.

Authors:  H Ha; M R Yu; K H Kim
Journal:  Free Radic Biol Med       Date:  1999-04       Impact factor: 7.376

6.  Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress.

Authors:  A Ceriello; F Mercuri; L Quagliaro; R Assaloni; E Motz; L Tonutti; C Taboga
Journal:  Diabetologia       Date:  2001-07       Impact factor: 10.122

7.  Platelet-derived growth factor synthesis in mesangial cells: induction by multiple peptide mitogens.

Authors:  B J Silver; F E Jaffer; H E Abboud
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

8.  Prooxidant activity of melatonin promotes fas-induced cell death in human leukemic Jurkat cells.

Authors:  A Wölfler; H C Caluba; P M Abuja; G Dohr; K Schauenstein; P M Liebmann
Journal:  FEBS Lett       Date:  2001-08-03       Impact factor: 4.124

9.  The identification of calmodulin-binding sites on mitochondria in cultured 3T3 cells.

Authors:  R L Pardue; M A Kaetzel; S H Hahn; B R Brinkley; J R Dedman
Journal:  Cell       Date:  1981-02       Impact factor: 41.582

10.  Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells.

Authors:  Xueliang Du; Takeshi Matsumura; Diane Edelstein; Luciano Rossetti; Zsuzsanna Zsengellér; Csaba Szabó; Michael Brownlee
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

View more
  16 in total

1.  A melatonin-based fluorescence method for the measurement of mitochondrial complex III function in intact cells.

Authors:  Jian-Liang Fu; Hong-Mei Zhang; Hua Zhang; Amrita Kamat; Chih-Ko Yeh; Bin-Xian Zhang
Journal:  J Pineal Res       Date:  2013-08-17       Impact factor: 13.007

2.  Impaired mitochondrial complex III and melatonin responsive reactive oxygen species generation in kidney mitochondria of db/db mice.

Authors:  Hua Zhang; Hong-Mei Zhang; Li-Ping Wu; Dun-Xian Tan; Amrita Kamat; Yun-Qing Li; Michael S Katz; Hanna E Abboud; Russel J Reiter; Bin-Xian Zhang
Journal:  J Pineal Res       Date:  2011-05-27       Impact factor: 13.007

Review 3.  Melatonin, mitochondria, and the cancer cell.

Authors:  Sara Proietti; Alessandra Cucina; Mirko Minini; Mariano Bizzarri
Journal:  Cell Mol Life Sci       Date:  2017-08-07       Impact factor: 9.261

Review 4.  The melatonin immunomodulatory actions in radiotherapy.

Authors:  M Najafi; A Shirazi; E Motevaseli; Gh Geraily; F Norouzi; M Heidari; S Rezapoor
Journal:  Biophys Rev       Date:  2017-03-27

5.  Astrocyte activation: a key step in rotenone induced cytotoxicity and DNA damage.

Authors:  Supriya Swarnkar; Sarika Singh; Poonam Goswami; Ramesh Mathur; Ishan K Patro; Chandishwar Nath
Journal:  Neurochem Res       Date:  2012-07-31       Impact factor: 3.996

6.  Rotenone-induced oxidative stress and apoptosis in human liver HepG2 cells.

Authors:  M A Siddiqui; J Ahmad; N N Farshori; Q Saquib; S Jahan; M P Kashyap; M Ahamed; J Musarrat; A A Al-Khedhairy
Journal:  Mol Cell Biochem       Date:  2013-08-21       Impact factor: 3.396

Review 7.  Utilization of redox modulating small molecules that selectively act as pro-oxidants in cancer cells to open a therapeutic window for improving cancer therapy.

Authors:  M S Petronek; J M Stolwijk; S D Murray; E J Steinbach; Y Zakharia; G R Buettner; D R Spitz; B G Allen
Journal:  Redox Biol       Date:  2021-01-16       Impact factor: 10.787

8.  A Comparison of B16 Melanoma Cells and 3T3 Fibroblasts Concerning Cell Viability and ROS Production in the Presence of Melatonin, Tested Over a Wide Range of Concentrations.

Authors:  Maria Angeles Bonmati-Carrion; Nuria Alvarez-Sánchez; Rüdiger Hardeland; Juan Antonio Madrid; Maria Angeles Rol
Journal:  Int J Mol Sci       Date:  2013-02-14       Impact factor: 5.923

9.  Geldanamycin derivative ameliorates high fat diet-induced renal failure in diabetes.

Authors:  Hong-Mei Zhang; Howard Dang; Amrita Kamat; Chih-Ko Yeh; Bin-Xian Zhang
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

10.  Melatonin enhances photo-oxidation of 2',7'-dichlorodihydrofluorescein by an antioxidant reaction that renders N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK).

Authors:  David Hevia; Juan C Mayo; Dun-Xian Tan; Aida Rodriguez-Garcia; Rosa M Sainz
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.